Nonmedical use of prescription stimulants in the United States

Drug and Alcohol Dependence

Volumn 84, Issue 2, 2006, Pages 135-143

  Kroutil, Larry A ^a   Van Brunt, David L ^b   Herman Stahl, Mindy A ^a   Heller, David C ^a   Bray, Robert M ^a   Penne, Michael A ^a  

^a RTI INTERNATIONAL   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Correlates; Methamphetamine; Nonmedical use; Stimulants

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHAMPHETAMINE; METHYLPHENIDATE; PEMOLINE MAGNESIUM;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG ABUSE; DRUG DEPENDENCE; DRUG MISUSE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATCHMENT AREA (HEALTH); CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; PRESCRIPTIONS, DRUG; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33746681239     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.12.011     Document Type: Article

References (31)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
2. American Academy of Pediatrics, Subcommittee on Attention-Deficit/Hyperactivity Disorder, and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108 4 (2001) 1033-1044
3. Barkley R.A., Fischer M., Smallish L., and Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111 (2003) 97-109
4. Barkley R.A., McMurray M.B., Edelbrock C.S., and Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86 (1990) 184-192
5. Biederman J. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. J. Clin. Psychiatry 64 Suppl. 11 (2003) 3-8
6. Degrandpre R. Ritalin Nation: Rapid-Fire Culture and the Transformation of Human Consciousness (2000), W.W. Norton & Company, New York
7. Drug and Alcohol Services Information System. Primary Methamphetamine/Amphetamine Treatment Admissions: 1992-2002 (2004)
8. Faraone S.V., Spencer T., Aleardi M., Pagano C., and Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol. 24 (2004) 24-29
9. Fischer M., and Barkley R.A. Childhood stimulant treatment and risk for later substance abuse. J. Clin. Psychiatry 64 Suppl 11 (2003) 19-23
10. Goldman L.S., Genel M., Bezman R.J., and Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 279 (1998) 1100-1107
11. Hechtman L., and Greenfield B. Long-term use of stimulants in children with attention-deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr. Drugs 5 (2003) 787-794
12. Kociancic T., Reed M.D., and Findling R.L. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children. Expert. Opin. Drug Saf. 3 (2004) 93-100
13. Kroutil, L.A., Handley, W., 2004. General Principles and Procedures for Editing Drug Use Data in the 2002 NSDUH Computer-Assisted Interview. In 2002 National Survey on Drug Use and Health: Methodological resource book (prepared for the Substance Abuse and Mental Health Services Administration under Contract No. 283-98-9008). RTI International, Research Triangle Park, NC (available at http://www.drugabusestatistics.samhsa.gov/nhsda/2k2MRB/2k2EditsCore.pdf) .
14. McCabe S.E., Teter C.J., and Boyd C.J. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst. Use Missue 39 (2004) 1095-1116
15. Robison L.M., Sclar D.A., Skaer T.L., and Galin R.S. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clin. Pediatr. (PA) 38 (1999) 209-217
16. RTI International. SUDAAN User's Manual: Release 8.0 (2001), RTI International, Research Triangle Park, NC
17. Stockl K.M., Hughes T.E., Jarrar M.A., Secnik K., and Perwien A.R. Physician perceptions of the use of medications for attention deficit hyperactivity disorder. J. Manage. Care Pharm. 9 (2003) 416-423
18. Strom, K.J., Wong, L., Fornnarino, L., Eicheldinger, C., Bethke, A., Ancheta, J., Rachal, V., 2004. The National Forensic Laboratory Information System: 2003 Annual Report. U.S. Drug Enforcement Administration, Washington, DC.
19. Substance Abuse and Mental Health Services Administration (SAMHSA), 2003. Results from the 2002 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration, Rockville, MD (Office of Applied Studies, NSDUH Series H-22, DHHS Publication No. SMA 03-3836).
20. Substance Abuse and Mental Health Services Administration (SAMHSA), 2004a. Results from the 2003 National Survey on Drug Use and Health: Detailed Tables. Accessed October 8, 2004, at: http://www.drugabusestatistics.samhsa.gov/nhsda/2k3tabs/PDF/2k3tabs.pdf.
21. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies, 2004b. National Survey on Drug Use and Health, 2002 (computer file), second ICPSR version. Research Triangle Institute (producer), Research Triangle Park, NC, 2004. Inter-university Consortium for Political and Social Research (distributor) Ann Arbor, MI (available at http://www.icpsr.umich.edu/SAMHDA/).
22. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies, 2004c. National Household Survey on Drug Abuse, 2000 (computer file), third ICPSR version. Research Triangle Institute (producer), Research Triangle Park, NC, 2004. Inter-university Consortium for Political and Social Research (distributor), Ann Arbor, MI (available at http://www.icpsr.umich.edu/SAMHDA/).
23. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies, 2004d. National Household Survey on Drug Abuse, 2001 (Computer file), second ICPSR version. Research Triangle Institute (producer), Research Triangle Park, NC, 2002. Inter-university Consortium for Political and Social Research (distributor), Ann Arbor, MI (available at http://www.icpsr.umich.edu/SAMHDA/).
24. Substance Abuse and Mental Health Services Administration (SAMHSA), 2005. Results from the 2004 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-28, DHHS Publication No. SMA 05-4062), Rockville, MD.
25. United States Food and Drug Administration, 2005a. Public Health Advisory for Adderall and Adderall XR. Accessed August 24, 2005 at: http://www.fda.gov/cder/drug/advisory/adderall.htm.
26. United States Food and Drug Administration, 2005b. Statement on Concerta and Methylphenidate for the June 30, 2005 Pediatric Advisory Committee. Accessed August 24, 2005 at: http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4152s2_07_Murphy.ppt.
27. United States General Accounting Office. Attention Disorder Drugs: Few Incidents of Diversion or Abuse Identified by Schools (GAO-01-1011) (2001), United States General Accounting Office, Washington, DC
28. Wilens T.E., Faraone S.V., Biederman J., and Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111 (2003) 179-185
29. Woodworth, T., 2000. Statement of Terrance Woodworth, Deputy Director, Office of Diversion Control, Drug Enforcement Administration, before the Committee on Education and the Workforce, Subcommittee on Early Childhood, Youth, and Families, May 16, 2000.
30. Wu L.T., and Schlenger W.E. Psychostimulant dependence in a community sample. Subst. Use Misuse 38 (2003) 221-248
31. Zamiska, N., 2004. Pressed to do well on admissions tests, students take drugs-stimulants prescribed for attention disorders find new unapproved use. The Wall Street Journal. A1 ed., November 8, 2004.